Otsuka Pharma obtains registration in Japan for new pro patch”, for percutaneous application of a dopamine receptor agonist “

Dec 25, 2012

Indications are Parkinson’s disease and idiopathic restless legs syndrome

Otsuka Pharma press release, Dec. 25, 2012